• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MacroGenics Inc

+ Add to Watchlist

MGNX:US

20.2000 USD 0.8900 4.22%

As of 20:10:00 ET on 07/28/2014.

Snapshot for MacroGenics Inc (MGNX)

Open: 21.0900 Day's Range: 20.0000 - 21.1000 Volume: 112,232
Previous Close: 21.0900 52wk Range: 17.9600 - 41.0000 1-Yr Rtn: -

Stock Chart for MGNX

No chart data available.
  • MGNX:US 20.2400
  • 1D
  • 1M
  • 1Y
21.0900
Interactive MGNX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MGNX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.3570
Est. PEG Ratio -
Market Cap (M USD) 557.92
Shares Outstanding (M) 27.62
30 Day Average Volume 291,154
Price/Book (mrq) 3.6254
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MGNX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MGNX

MacroGenics Inc. develops novel biologics. The Company specializes in treatments for autoimmune disorders, cancer, and infectious diseases. MacroGenics serves the healthcare industry in the United States.

Scott KoenigPresident/CEO/Co-FounderJames Karrels "Jim"CFO/VP/Secretary
Ezio BonviniSenior VP:ResearchKathryn SteinSenior VP:Product Dev
More Company Profile & Key Executives for MGNX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil